FDA Drug recall D-1054-2014
Cefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplex container, For IV Use Only, Sing…
- FDA Drug
- Class I
- terminated
- Published 2014-02-12
On 2014-02-12 the FDA classified a Class I recall of Cefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplex container, For IV Use Only, Sing… by B Braun Medical, citing presence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample u….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1054-2014 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2013-10-15 |
| Published | 2014-02-12 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | B Braun Medical |
| Distribution | US |
Product
Cefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplex container, For IV Use Only, Single Dose, Sterile/Non pyrogenic, Rx Only, B Braun Medical Inc., NDC 0264-3193-11
Reason
Presence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit.
Identifiers
| ndc | 0264-3193-11 |
|---|---|
| ndc | 0264-3195-11 |
| code_info | Lot H3A744, Exp 01/15 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1054-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.